End-of-day quote
Johannesburg S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
220.7
ZAR
|
+1.98%
|
|
+1.70%
|
+8.46%
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
45,802
|
65,412
|
73,836
|
62,047
|
81,701
|
98,204
|
-
|
-
|
Enterprise Value (EV)
1 |
84,786
|
100,640
|
90,136
|
78,111
|
100,071
|
120,108
|
117,283
|
112,320
|
P/E ratio
|
6.38
x
|
14
x
|
15.4
x
|
9.71
x
|
15.6
x
|
16.8
x
|
11.7
x
|
10.3
x
|
Yield
|
3.14%
|
-
|
1.62%
|
2.34%
|
1.86%
|
1.66%
|
2.07%
|
2.35%
|
Capitalization / Revenue
|
1.18
x
|
1.69
x
|
1.96
x
|
1.61
x
|
2.01
x
|
2.2
x
|
1.94
x
|
1.8
x
|
EV / Revenue
|
2.18
x
|
2.6
x
|
2.39
x
|
2.02
x
|
2.46
x
|
2.7
x
|
2.31
x
|
2.06
x
|
EV / EBITDA
|
7.83
x
|
9.18
x
|
9.06
x
|
7.09
x
|
9.02
x
|
10.8
x
|
8.39
x
|
7.28
x
|
EV / FCF
|
23.8
x
|
18.1
x
|
26.6
x
|
29.2
x
|
42.8
x
|
-192
x
|
14.1
x
|
9.68
x
|
FCF Yield
|
4.2%
|
5.53%
|
3.77%
|
3.43%
|
2.34%
|
-0.52%
|
7.12%
|
10.3%
|
Price to Book
|
0.83
x
|
0.95
x
|
1.13
x
|
0.89
x
|
0.95
x
|
1.09
x
|
1.02
x
|
0.96
x
|
Nbr of stocks (in thousands)
|
455,970
|
455,800
|
455,522
|
446,252
|
444,946
|
444,946
|
-
|
-
|
Reference price
2 |
100.4
|
143.5
|
162.1
|
139.0
|
183.6
|
220.7
|
220.7
|
220.7
|
Announcement Date
|
9/11/19
|
9/9/20
|
9/1/21
|
8/31/22
|
8/30/23
|
-
|
-
|
-
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
38,872
|
38,647
|
37,766
|
38,606
|
40,709
|
44,557
|
50,721
|
54,415
|
EBITDA
1 |
10,824
|
10,968
|
9,945
|
11,012
|
11,100
|
11,141
|
13,983
|
15,418
|
EBIT
1 |
5,528
|
7,060
|
7,072
|
8,671
|
7,822
|
9,020
|
11,912
|
13,254
|
Operating Margin
|
14.22%
|
18.27%
|
18.73%
|
22.46%
|
19.21%
|
20.24%
|
23.49%
|
24.36%
|
Earnings before Tax (EBT)
1 |
3,490
|
5,602
|
5,989
|
8,134
|
6,555
|
7,815
|
10,865
|
12,186
|
Net income
1 |
7,182
|
4,664
|
4,806
|
6,488
|
5,228
|
6,228
|
8,458
|
9,724
|
Net margin
|
18.48%
|
12.07%
|
12.73%
|
16.81%
|
12.84%
|
13.98%
|
16.68%
|
17.87%
|
EPS
2 |
15.74
|
10.22
|
10.53
|
14.32
|
11.77
|
13.13
|
18.85
|
21.44
|
Free Cash Flow
1 |
3,560
|
5,570
|
3,394
|
2,677
|
2,339
|
-627
|
8,347
|
11,609
|
FCF margin
|
9.16%
|
14.41%
|
8.99%
|
6.93%
|
5.75%
|
-1.41%
|
16.46%
|
21.33%
|
FCF Conversion (EBITDA)
|
32.89%
|
50.78%
|
34.13%
|
24.31%
|
21.07%
|
-
|
59.69%
|
75.3%
|
FCF Conversion (Net income)
|
49.57%
|
119.43%
|
70.62%
|
41.26%
|
44.74%
|
-
|
98.69%
|
119.39%
|
Dividend per Share
2 |
3.150
|
-
|
2.620
|
3.260
|
3.420
|
3.672
|
4.576
|
5.191
|
Announcement Date
|
9/11/19
|
9/9/20
|
9/1/21
|
8/31/22
|
8/30/23
|
-
|
-
|
-
|
Fiscal Period: June |
2020 S1
|
2021 S1
|
2022 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
18,417
|
-
|
19,225
|
-
|
23,873
|
EBITDA
1 |
5,260
|
-
|
5,296
|
-
|
6,407
|
EBIT
1 |
3,644
|
-
|
4,113
|
-
|
6,064
|
Operating Margin
|
19.79%
|
-
|
21.39%
|
-
|
25.4%
|
Earnings before Tax (EBT)
|
2,969
|
-
|
3,940
|
-
|
-
|
Net income
1 |
2,629
|
2,549
|
3,128
|
2,314
|
4,294
|
Net margin
|
14.27%
|
-
|
16.27%
|
-
|
17.99%
|
EPS
|
-
|
5.584
|
9.758
|
5.208
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
4.000
|
Announcement Date
|
3/5/20
|
3/11/21
|
8/31/22
|
1/15/24
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
38,984
|
35,228
|
16,300
|
16,064
|
18,370
|
21,904
|
19,079
|
14,116
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.602
x
|
3.212
x
|
1.639
x
|
1.459
x
|
1.655
x
|
1.966
x
|
1.364
x
|
0.9155
x
|
Free Cash Flow
1 |
3,560
|
5,570
|
3,394
|
2,677
|
2,339
|
-627
|
8,347
|
11,609
|
ROE (net income / shareholders' equity)
|
12.4%
|
10.8%
|
8.87%
|
9.5%
|
6.65%
|
7.22%
|
9.17%
|
9.65%
|
ROA (Net income/ Total Assets)
|
5.06%
|
5.23%
|
4.92%
|
-
|
4.26%
|
4.99%
|
6.32%
|
-
|
Assets
1 |
141,956
|
89,124
|
97,621
|
-
|
122,830
|
124,754
|
133,845
|
-
|
Book Value Per Share
2 |
120.0
|
152.0
|
144.0
|
157.0
|
194.0
|
202.0
|
216.0
|
230.0
|
Cash Flow per Share
2 |
13.10
|
18.10
|
15.00
|
11.90
|
12.40
|
26.90
|
15.70
|
20.40
|
Capex
1 |
3,583
|
2,690
|
3,431
|
2,697
|
3,181
|
4,200
|
2,900
|
-
|
Capex / Sales
|
9.22%
|
6.96%
|
9.08%
|
6.99%
|
7.81%
|
9.43%
|
5.72%
|
-
|
Announcement Date
|
9/11/19
|
9/9/20
|
9/1/21
|
8/31/22
|
8/30/23
|
-
|
-
|
-
|
Last Close Price
220.7
ZAR Average target price
232
ZAR Spread / Average Target +5.14% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.46% | 5.22B | | +19.62% | 43.34B | | +20.44% | 21.96B | | +10.86% | 14.09B | | +13.07% | 13.64B | | +37.46% | 11.43B | | -8.59% | 6.86B | | -0.05% | 6.79B | | -8.87% | 5.73B | | -4.29% | 4.71B |
Generic Pharmaceuticals
|